Thrombolytic Therapy of Pulmonary Embolism
Tài liệu tham khảo
Coon, 1959, Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment, Am J Cardiol, 4, 611, 10.1016/0002-9149(59)90145-6
Dalen, 1975, Natural history of pulmonary embolism, Prog Cardiovasc Dis, 17, 259, 10.1016/S0033-0620(75)80017-X
Bell, 1982, Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention and treatment, Am Heart J, 103, 239, 10.1016/0002-8703(82)90498-7
Lilienfeld, 1990, Mortality from pulmonary embolism in the United States: 1962 to 1984, Chest, 98, 1067, 10.1378/chest.98.5.1067
Morrell, 1968, The post-mortem incidence of pulmonary embolism in a hospital population, Br J Surg, 55, 347, 10.1002/bjs.1800550506
Uhland, 1964, Pulmonary embolism: a commonly missed clinical entity, Dis Chest, 45, 533, 10.1378/chest.45.5.533
Goldhaber, 1982, Factors associated with correct antemortem diagnosis of major pulmonary embolism, Am J Med, 73, 822, 10.1016/0002-9343(82)90764-1
Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016
Barritt, 1960, Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial, Lancet, 1, 1309, 10.1016/S0140-6736(60)92299-6
Sasahara, 1983, Pulmonary thromboembolism: diagnosis and treatment, JAMA, 249, 2945, 10.1001/jama.1983.03330450075032
Hermann, 1961, Pulmonary embolism: a clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants, Am J Surg, 102, 19, 10.1016/0002-9610(61)90680-8
1970, Urokinase Pulmonary Embolism Trial: phase 1 results—a cooperative study, JAMA, 214, 2163, 10.1001/jama.1970.03180120035007
1974, Urokinase-Streptokinase Embolism Trial: phase 2 results—a cooperative study, JAMA, 229, 1606, 10.1001/jama.1974.03230500024021
Carson, 1992, The clinical course of pulmonary embolism, N Engl J Med, 326, 1240, 10.1056/NEJM199205073261902
Ferrari, 1997, Clinical epidemiology of venous thromboembolic disease: results of a French multicentre registry, Eur Heart J, 18, 685, 10.1093/oxfordjournals.eurheartj.a015316
Lund, 1987, Pulmonary embolism: long-term follow-up after treatment with full-dose heparin, streptokinase or embolectomy, Acta Med Scand, 221, 61, 10.1111/j.0954-6820.1987.tb01246.x
Alpert, 1976, Mortality in patients treated for pulmonary embolism, JAMA, 236, 1477, 10.1001/jama.1976.03270140029017
Dalla-Volta, 1992, PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: Plasminogen Activator Italian Multicenter Study 2, J Am Coll Cardiol, 20, 520, 10.1016/0735-1097(92)90002-5
Goldhaber, 1993, Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion, Lancet, 341, 507, 10.1016/0140-6736(93)90274-K
Kasper, 1997, Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry, J Am Coll Cardiol, 30, 1165, 10.1016/S0735-1097(97)00319-7
Konstantinides, 1997, Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry, Circulation, 96, 882, 10.1161/01.CIR.96.3.882
Monreal, 1989, Recurrent pulmonary embolism: a prospective study, Chest, 95, 976, 10.1378/chest.95.5.976
Paraskos, 1973, Late prognosis of acute pulmonary embolism, N Engl J Med, 289, 55, 10.1056/NEJM197307122890201
Phear, 1960, Pulmonary embolism: a study of late prognosis, Lancet, 2, 832, 10.1016/S0140-6736(60)91903-6
van Beek, 1997, The clinical course of patients with suspected pulmonary embolism, Arch Intern Med, 157, 2593, 10.1001/archinte.1997.00440430075009
Wheeler, 1988, Physician practices in the treatment of pulmonary embolism and deep vein thrombosis, Arch Intern Med, 148, 1321, 10.1001/archinte.1988.00380060085018
Walker, 1970, Resolution of pulmonary embolism, BMJ, 4, 135, 10.1136/bmj.4.5728.135
Goldhaber, 1995, The international cooperative pulmonary embolism registry, Chest, 108, 302, 10.1378/chest.108.2.302
Girard, 1987, Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study, Thorax, 42, 481, 10.1136/thx.42.7.481
Dalen, 1969, Resolution rate of acute pulmonary embolism in man, N Engl J Med, 280, 1194, 10.1056/NEJM196905292802202
Fred, 1966, Rapid resolution of pulmonary thromboemboli in man: angiographic study, JAMA, 196, 1137, 10.1001/jama.1966.03100260075021
Tow, 1967, Recovery of pulmonary arterial blood flow in patients with pulmonary embolism, N Engl J Med, 276, 1053, 10.1056/NEJM196705112761902
Cook, 1995, Clinical recommendations using levels of evidence for antithrombotic agents, Chest, 108, 227S, 10.1378/chest.108.4_Supplement.227S
Sharma, 1982, Thrombolytic therapy, N Engl J Med, 306, 1268, 10.1056/NEJM198205273062105
Marder, 1988, Thrombolytic therapy: current status, N Engl J Med, 318, 1512, 10.1056/NEJM198806093182306
Loscalzo, 1990, An overview of thrombolytic agents, Chest, 97, 117S, 10.1378/chest.97.4_Supplement.117S
Hyers, 1995, Antithrombotic therapy for venous thromboembolic disease, Chest, 108, 335S, 10.1378/chest.108.4_Supplement.335S
Gulba, 1996, Thrombolytic agents: an overview, Ann Hematol, 73, S9
Agnelli, 1992, Bolus thrombolysis in venous thromboembolism, Chest, 101, 172S, 10.1378/chest.101.4_Supplement.172S
Agnelli, 1997, Rationale for the bolus administration of fibrin-specific thrombolytic agents, Fibrinolysis & Proteolysis, 11, 23, 10.1016/S0268-9499(97)80066-5
Agnelli, 1990, Rationale for bolus t-PA therapy to improve efficacy and safety, Chest, 97, 161S, 10.1378/chest.97.4_Supplement.161S
Agnelli, 1997, Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism, Blood Coagul Fibrinolysis, 8, 216, 10.1097/00001721-199706000-00002
Goldhaber, 1986, Acute pulmonary embolism treated with tissue plasminogen activator, Lancet, 2, 886, 10.1016/S0140-6736(86)90411-3
Goldhaber, 1988, Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism, Lancet, 2, 293, 10.1016/S0140-6736(88)92354-9
Browse, 1964, Streptokinase and pulmonary embolism, Lancet, 11, 1039, 10.1016/S0140-6736(64)90991-2
Genton, 1968, Urokinase therapy in pulmonary thromboembolism, Am Heart J, 76, 628, 10.1016/0002-8703(68)90161-0
Miller, 1969, Treatment of pulmonary embolism with streptokinase: a preliminary report, BMJ, 1, 812, 10.1136/bmj.1.5647.812
Miller, 1971, Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism, BMJ, 2, 681, 10.1136/bmj.2.5763.681
Sautter, 1967, Urokinase for the treatment of acute pulmonary thromboembolism, JAMA, 202, 215, 10.1001/jama.1967.03130160089019
Sasahara, 1967, Urokinase therapy in clinical pulmonary embolism: a new thrombolytic agent, N Engl J Med, 277, 1168, 10.1056/NEJM196711302772203
Tow, 1967, Urokinase in pulmonary embolism, N Engl J Med, 277, 1161, 10.1056/NEJM196711302772202
Dickie, 1974, Hemodynamic effects of bolus infusion of urokinase in pulmonary thromboembolism, Am Rev Respir Dis, 109, 48
Hirsh, 1968, Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems, BMJ, 4, 729, 10.1136/bmj.4.5633.729
Sharma, 1980, Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism, N Engl J Med, 303, 842, 10.1056/NEJM198010093031502
Tibbutt, 1974, Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism, BMJ, 1, 343, 10.1136/bmj.1.5904.343
Ly, 1978, A controlled trial of streptokinase and heparin in the treatment of major pulmonary embolism, Acta Med Scand, 203, 465, 10.1111/j.0954-6820.1978.tb14909.x
Marini, 1988, Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial, Respiration, 54, 162, 10.1159/000195517
PIOPED Investigators, 1990, Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study by the PIOPED Investigators, Chest, 97, 528, 10.1378/chest.97.3.528
Levine, 1990, A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism, Chest, 98, 1473, 10.1378/chest.98.6.1473
Jerjes-Sanchez, 1995, Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial, J Thromb Thrombolysis, 2, 227, 10.1007/BF01062714
Sharma, 1990, Long-term hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease [abstract], J Am Coll Cardiol, 15, 65A, 10.1016/0735-1097(90)91976-2
Meyer, 1992, Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial, J Am Coll Cardiol, 19, 239, 10.1016/0735-1097(92)90472-Y
Goldhaber, 1992, Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial, J Am Coll Cardiol, 20, 24, 10.1016/0735-1097(92)90132-7
Meneveau, 1997, Streptokinase vs alteplase in massive pulmonary embolism: a randomized trial assessing right heart hemodynamics and pulmonary vascular obstruction, Eur Heart J, 18, 1141, 10.1093/oxfordjournals.eurheartj.a015410
Meneveau, 1998, Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up, J Am Coll Cardiol, 31, 1057, 10.1016/S0735-1097(98)00068-0
Tapson, 1992, Rapid thrombolysis of massive pulmonary emboli without systemic fibrinogenolysis: intraembolic infusion of thrombolytic therapy [abstract], Am Rev Respir Dis, 145, A719
Schwarz, 1985, Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism, Circulation, 71, 117, 10.1161/01.CIR.71.1.117
Petitpretz, 1984, Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial, Circulation, 70, 861, 10.1161/01.CIR.70.5.861
Vujic, 1983, Massive pulmonary embolism: treatment with full heparinization and topical low-dose streptokinase, Radiology, 148, 671, 10.1148/radiology.148.3.6878682
Leeper, 1988, Treatment of massive acute pulmonary embolism: the use of low doses of intrapulmonary arterial streptokinase combined with full doses of systemic heparin, Chest, 93, 234, 10.1378/chest.93.2.234
Gallus, 1975, Thrombolysis with a combination of small doses of streptokinase and full doses of heparin, Semin Thromb & Hemost, 2, 14, 10.1055/s-0028-1086112
Edwards, 1973, Low-dose urokinase in major pulmonary embolism, Lancet, 2, 409, 10.1016/S0140-6736(73)92273-3
Barberena, 1983, Intraarterial infusion of urokinase in the treatment of acute pulmonary thromboembolism: preliminary observations, AJR Am J Roentgenol, 140, 883, 10.2214/ajr.140.5.883
Verstraete, 1988, Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism, Circulation, 77, 353, 10.1161/01.CIR.77.2.353
Fava, 1997, Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism, J Vasc Interv Radiol, 8, 261, 10.1016/S1051-0443(97)70552-9
Stern, 1988, Urokinase versus tissue plasminogen activator in pulmonary embolism, Lancet, 2, 691
Diehl, 1992, Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism, Am J Cardiol, 70, 1477, 10.1016/0002-9149(92)90302-F
Goldhaber, 1994, Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomized trial, Chest, 106, 718, 10.1378/chest.106.3.718
Goldhaber, 1994, Two trials of reduced bolus alteplase in the treatment of pulmonary embolism: an overview, Chest, 106, 725, 10.1378/chest.106.3.725
Sors, 1994, Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism: a randomized controlled multicenter trial, Chest, 106, 712, 10.1378/chest.106.3.712
Palla, 1997, Resolution of pulmonary embolism: effect of therapy and putative age of emboli, Respiration, 64, 50, 10.1159/000196642
Daniels, 1997, Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism, Am J Cardiol, 80, 184, 10.1016/S0002-9149(97)00315-9
Levine, 1995, Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism, Chest, 108, 291S, 10.1378/chest.108.4_Supplement.291S
Kanter, 1997, Thrombolytic therapy for pulmonary embolism: frequency of intracranial hemorrhage and associated risk factors, Chest, 111, 1241, 10.1378/chest.111.5.1241
Lualdi, 1995, Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications, Am Heart J, 130, 1276, 10.1016/0002-8703(95)90155-8
Goldhaber, 1997, Pulmonary embolism thrombolysis: broadening the paradigm for its administration, Circulation, 96, 716, 10.1161/01.CIR.96.3.716
Goldhaber, 1995, Thrombolytic therapy in venous thromboembolism: clinical trials and current indications, Clin Chest Med, 16, 307, 10.1016/S0272-5231(21)01094-7
1996, Opinions regarding the diagnosis and management of venous thromboembolic disease: ACCP Consensus Committee on Pulmonary Embolism, Chest, 109, 233, 10.1378/chest.109.1.233
Goodman, 1995, Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography, AJR Am J Roentgenol, 164, 1369, 10.2214/ajr.164.6.7754875
Remy-Jardin, 1996, Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy, Radiology, 200, 699, 10.1148/radiology.200.3.8756918
van Rossum, 1996, Pulmonary embolism: validation of spiral CT angiography in 149 patients, Radiology, 201, 467, 10.1148/radiology.201.2.8888242
van Rossum, 1996, Role of spiral volumetric computed tomographic scanning in the assessment of patients with clinical suspicion of pulmonary embolism and an abnormal ventilation/perfusion scan, Thorax, 51, 23, 10.1136/thx.51.1.23
Gefter, 1995, Pulmonary thromboembolism: recent developments in diagnosis with CT and MR imaging, Radiology, 197, 561, 10.1148/radiology.197.3.7480717
Blum, 1994, Spiral-computed tomography versus pulmonary angiography in the diagnosis of acute massive pulmonary embolism, Am J Cardiol, 74, 96, 10.1016/0002-9149(94)90502-9
Kasper, 1986, Echocardiographic findings in patients with proved pulmonary embolism, Am Heart J, 112, 1284, 10.1016/0002-8703(86)90361-3
Jardin, 1987, Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement, J Am Coll Cardiol, 10, 1201, 10.1016/S0735-1097(87)80119-5
Come, 1987, Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator, J Am Coll Cardiol, 10, 971, 10.1016/S0735-1097(87)80333-9
Come, 1992, Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions, Chest, 101, 151S, 10.1378/chest.101.4_Supplement.151S
McConnell, 1996, Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism, Am J Cardiol, 78, 469, 10.1016/S0002-9149(96)00339-6
1980, Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference, Ann Intern Med, 93, 141, 10.7326/0003-4819-93-1-141
Goldhaber, 1995, Contemporary pulmonary embolism thrombolysis, Chest, 107, 45S, 10.1378/chest.107.1_Supplement.45S
Goldhaber, 1991, Recent advances in the diagnosis and lytic therapy of pulmonary embolism, Chest, 99, 173S, 10.1378/chest.99.4.173S